Jennifer L Muzyka

Suggest Changes
Learn More
Given that immunoproteasome inhibitors are currently being developed for a variety of potent therapeutic purposes, the unique specificity of an α',β'-epoxyketone peptide (UK101) toward the LMP2(More)
  • 1